# INmune Bio Sets $4.5 Million Registered Direct Offering and Warrant Placement

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/42752
Published: 2026-10-28T16:36:38.000Z
Updated: 2026-10-28T16:36:38.000Z
Section: Business

> The agreement pairs a sale of 3 million common shares with unregistered warrants covering up to 3 million additional shares.

INmune Bio Inc. agreed to sell 3 million common shares and place warrants for up to 3 million additional shares, a transaction expected to generate approximately $4.5 million in gross proceeds.

The share sale is a registered direct offering to an institutional investor. A concurrent private placement covers unregistered warrants that can be exercised for up to 3 million more shares.

The expected proceeds are before placement-agent fees and other estimated offering expenses. The company announced the agreement Wednesday, Oct. 28.